163 related articles for article (PubMed ID: 37821271)
1. Cardiovascular disease in transgender individuals.
Murphy CN; Delles C; Davies E; Connelly PJ
Atherosclerosis; 2023 Nov; 384():117282. PubMed ID: 37821271
[TBL] [Abstract][Full Text] [Related]
2. Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.
Hashemi L; Marijic Buljubasic A; Budoff MJ; Copeland LA; Jackson NJ; Jasuja GK; Gornbein J; Reue K
JAMA Netw Open; 2024 Jul; 7(7):e2419696. PubMed ID: 38954413
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
4. The cardiovascular subtleties of testosterone on gender-affirming hormone therapy.
Santos JD; Oliveira-Neto JT; Tostes RC
Am J Physiol Heart Circ Physiol; 2023 Jul; 325(1):H30-H53. PubMed ID: 37145958
[TBL] [Abstract][Full Text] [Related]
5. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
[TBL] [Abstract][Full Text] [Related]
6. Th17 cell-linked mechanisms mediate vascular dysfunction induced by testosterone in a mouse model of gender-affirming hormone therapy.
Santos JD; Oliveira-Neto JT; Barros PR; Damasceno LEA; Lautherbach N; Assis AP; Silva CAA; Sorgi CA; Faccioli LH; Kettelhut IC; Salgado HC; Carneiro FS; Alves-Filho JC; Tostes RC
Am J Physiol Heart Circ Physiol; 2022 Aug; 323(2):H322-H335. PubMed ID: 35714175
[TBL] [Abstract][Full Text] [Related]
7. Chronic Kidney Disease in the Transgender, Nonbinary, or Gender Diverse Person.
Collister D; Krakowsky Y; Potter E; Millar AC
Semin Nephrol; 2022 Mar; 42(2):129-141. PubMed ID: 35718361
[TBL] [Abstract][Full Text] [Related]
8. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.
Nguyen HB; Chavez AM; Lipner E; Hantsoo L; Kornfield SL; Davies RD; Epperson CN
Curr Psychiatry Rep; 2018 Oct; 20(12):110. PubMed ID: 30306351
[TBL] [Abstract][Full Text] [Related]
9. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy.
Karalexi MA; Frisell T; Cnattingius S; Holmberg D; Holmberg M; Kollia N; Skalkidou A; Papadopoulos FC
Eur J Prev Cardiol; 2022 Nov; 29(15):2017-2026. PubMed ID: 35778824
[TBL] [Abstract][Full Text] [Related]
11. Gender-affirming pharmacotherapy and additional health considerations: A contemporary review.
Mercer J; Bandy S; Tang H; Wenger B; Ryan L; Lee G; Lipscomb J
J Am Pharm Assoc (2003); 2023; 63(6):1669-1676.e1. PubMed ID: 37619851
[TBL] [Abstract][Full Text] [Related]
12. Gender-affirming hormone therapy and cardiovascular health in transgender adults.
Ong C; Monita M; Liu M
Climacteric; 2024 Jun; 27(3):227-235. PubMed ID: 38597210
[TBL] [Abstract][Full Text] [Related]
13. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
[TBL] [Abstract][Full Text] [Related]
14. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
[TBL] [Abstract][Full Text] [Related]
15. Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults.
Connelly PJ; Marie Freel E; Perry C; Ewan J; Touyz RM; Currie G; Delles C
Hypertension; 2019 Dec; 74(6):1266-1274. PubMed ID: 31656099
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population.
Aranda G; Halperin I; Gomez-Gil E; Hanzu FA; Seguí N; Guillamon A; Mora M
Front Endocrinol (Lausanne); 2021; 12():718200. PubMed ID: 34659112
[TBL] [Abstract][Full Text] [Related]
18. Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature.
Tang GT; Zwickl S; Sinclair R; Zajac JD; Cheung AS
Clin Exp Dermatol; 2023 Sep; 48(10):1117-1127. PubMed ID: 37311161
[TBL] [Abstract][Full Text] [Related]
19. Gender minority stress in transgender people: a major role for social network.
Collet S; Kiyar M; Martens K; Vangeneugden J; Simpson VG; Guillamon A; Mueller SC; T'Sjoen G
J Sex Med; 2023 May; 20(6):905-917. PubMed ID: 37102304
[TBL] [Abstract][Full Text] [Related]
20. Characterising body composition and bone health in transgender individuals receiving gender-affirming hormone therapy.
Ford K; Huggins E; Sheean P
J Hum Nutr Diet; 2022 Dec; 35(6):1105-1114. PubMed ID: 35509260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
